Literature DB >> 3391807

Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Creteil experience (1971-1981).

J Crook1, J J Mazeron, G Marinello, M Martin, M Raynal, E Calitchi, M Faraldi, G Ganem, J P Le Bourgeois, B Pierquin.   

Abstract

Forty-eight patients with T1 or T2 epidermoid carcinomas of the base of tongue were treated at the Henri Mondor Hospital between 1971 and 1981. Forty-one patients received moderate dose 60Co external beam irradiation (mean: 48.6 Gy) to the primary tumor and regional nodes, followed by an interstitial iridium 192 implant to the primary tumor (mean: 32 Gy). This completed the treatment for the 30 node negative patients, but those with clinically positive nodes were managed by either an additional electron beam boost to the involved nodes or a neck dissection. Seven tumors were treated exclusively by implantation to the base of tongue (mean: 63 Gy). Five-year crude disease-free survival is 50% with 35% of patients dying of recurrent disease. Definitive local control for T1 lesions is 85% (11/13) and for T2 is 71% (25/35). A dose response effect was observed with local control of 79% (26/33) obtained with a combined dose greater than or equal to 75 Gy, but only 50% (4/8) for less than or equal to 70 Gy. For N0 patients definitive regional control is 97% and for N1-3 is 89%. Minor or moderate soft tissue ulceration was observed in 12 patients, including 3 cases that progressed to osteonecrosis. None required surgical intervention. No correlation exists between necrosis and tumor size or total dose.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391807     DOI: 10.1016/0360-3016(88)90353-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Quality of life of oropharyngeal cancer patients treated with brachytherapy.

Authors:  David N Teguh; Peter C Levendag; Inger-Karine Kolkman-Deurloo; Peter van Rooij; Paul I M Schmitz
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

2.  Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.

Authors:  Leechuan Andy Chen; Christopher J Anker; Jason P Hunt; Luke O Buchmann; Kenneth F Grossmann; Kenneth Boucher; Li-Ming Christine Fang; Dennis C Shrieve; Ying J Hitchcock
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

3.  Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series.

Authors:  Bengt Johansson; Leif Karlsson; Johan Reizenstein; Mathias von Beckerath; Lennart Hardell; Jan Persliden
Journal:  J Contemp Brachytherapy       Date:  2011-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.